To further explore the correlation between PIK3CA expression and the clinicopathological parameters of IBC, patients were categorized into two subgroups according to the average values of the Tumor/Non-tumor ratio (≥ 0.98). Here, PIK3CA is linked to inflammatory breast carcinoma.